Veru Inc. (NASDAQ: VERU) revealed the findings of phase III trials of antiviral medication for patients with severe COVID-19. In clinical studies, the sabizabulin candidate
State Reviewer provide quality information for free in a convenient place and format. You do not need to look for us – the news portal “State Reviewer” meets the reader every morning on the way to work in the metro, at traffic intersections, in cafes and business centers. Throughout the day on our social networking pages and at statereviewer.com you will find the most important information about cities, countries and worlds.